2024-01-08 08:46:55 ET
- Aclarion ( ACON ) +111% Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan.
- Harpoon Therapeutics ( HARP ) +110% stock surges as Merck reportedly in talks for $700M acquisition.
- Ambrx Biopharma ( AMAM ) +100% to acquire ADC developer Ambrx Biopharma for $2B
- Spectaire Holdings ( SPEC ) +73% .
- Vincerx Pharma ( VINC ) +47% Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma.
- Cyclacel Pharmaceuticals ( CYCC ) +26% .
- Axonics ( AXNX ) +21% stock jumps as Boston Scientific agrees to acquire in $3.7B deal.
- Ampio Pharmaceuticals ( AMPE ) +20% .
- Cellectar Biosciences ( CLRB ) +17% gains on pivotal data for radiotherapy.
- Addex Therapeutics ( ADXN ) +15% .
- 1847 Holdings ( EFSH ) +14% .
- DermTech ( DMTK ) +15% Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT).
- Heron Therapeutics ( HRTX ) +14% gains on deal to expand sales network for pain therapy Zynrelef.
- Butterfly Network ( BFLY ) +14% Announces FDA Clearance of its Next-Generation Handheld
- ( BROG ) +12% .
- LifeMD ( LFMD ) +11% Provides 2024 Financial Guidance.
- reAlpha Tech ( AIRE ) +9% .
- Akoya Biosciences ( AKYA ) +9% .
- LQR House ( LQR ) +9% .
- Lion Group Holding ( LGHL ) +9% .
- Crocs ( CROX ) +8% rallies after guiding full-year sales above expectations.
- Molecular Partners ( MOLN ) +8% Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference.
- Aurora Technology Acquisition ( ATAK ) +5% .
- Sphere 3D ( ANY ) +7% .
- QuantaSing Group ( QSG ) +7% .
For further details see:
AMPE, ANY and CYCC are among pre market gainers